<DOC>
	<DOCNO>NCT00545168</DOCNO>
	<brief_summary>A comparative safety efficacy study NatrOVA Creme Rinse - 1 % versus NIX Creme Rinse , actual use condition subject 6 month age great infested Pediculosis capitis ( Head louse ) .</brief_summary>
	<brief_title>Safety Efficacy Study NatrOVA Creme Rinse - 1 % NIX Creme Rinse Subjects 6 Months Older With Head Lice</brief_title>
	<detailed_description>This Phase 3 multi-site , randomize , evaluator/investigator-blinded , three-arm , parallel group study evaluate safety efficacy NatrOVA Creme Rinse - 1 % ( nit comb without nit comb ) versus NIX Creme Rinse `` actual use '' environment .</detailed_description>
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Lice Infestations</mesh_term>
	<mesh_term>Permethrin</mesh_term>
	<criteria>1 . Subjects must active head louse infestation present Day 0 . 2 . Subjects female male , least 6 month age . 3 . Subjects must good general health base medical history . 4 . Each subject must appropriately sign Informed Consent agreement . Subjects age 12 must also provide write oral assent . 5 . The subject/caregiver must able read English Spanish 7th grade level . 6 . The parent guardian within household must willing allow household member screen head louse . If household member find head lice infestation , also enrol study . 7 . Subjects must agree use form louse treatment course study must agree use exclude concomitant medication . 8 . Subjects must agree cut chemically treat hair period initial treatment final visit . 9 . Subjects/caregiver must demonstrate clear understand his/her requirement study participation agree comply study instruction . 1 . Individuals history irritation sensitivity pediculicides hair care product . 2 . Individuals visible skin/scalp condition treatment site , opinion investigative personnel Sponsor , interfere evaluation . 3 . Individuals require treatment topical salicylic acid , topical corticosteroid , anthralin , vitamin D analog , retinoids , immunosuppressant , topical hair growth formulation , topical dandruff treatment . 4 . Infested subject previously treat pediculicide within 48 hour prior study . 5 . Individuals condition illness , opinion Investigator , may compromise objective protocol . 6 . Individuals receive systemic topical drug medication , include systemic antibiotic , opinion investigative personnel study monitor may interfere study result . 7 . Individuals participate clinical trial within past 30 day . 8 . Individuals ( individual household ) , opinion Investigator , understand requirement study participation and/or may likely exhibit poor compliance . 9 . Individuals household member infested lice unwilling unable enroll study use standard course louse treatment . 10 . Females pregnant nursing . Females childbearing potential must negative urine pregnancy test prior treatment Day 0 . If household pregnant female active case head louse , entire household exclude participation . If pregnant household member louse , individual must NOT caregiver ( one provide treatment household member ) . 11 . Sexually active female use effective contraception . 12 . Individuals history drug abuse past year .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>head louse</keyword>
</DOC>